Champions Oncology

$11.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+2.11%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CSBR and other stocks, options, and ETFs commission-free!

About CSBR

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ. The listed name for CSBR is Champions Oncology, Inc. Common Stock.

CEO

Ronnie Morris

Employees

143

Headquarters

Hackensack, New Jersey

Founded

1985

Market Cap

153.84M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

18.05K

High Today

$11.74

Low Today

$11.23

Open Price

$11.37

Volume

22.02K

52 Week High

$13.45

52 Week Low

$4.02

Collections

CSBR Earnings

-$0.14

-$0.08

-$0.02

$0.04

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Mar 11, After Hours